本文へ移動
cccskills
無料GitHub で公開

es-cushing-hpa-axis-recovery-assessment

This skill recommends follow-up morning cortisol and/or ACTH stimulation tests or insulin-induced hypoglycemia to assess HPA axis recovery in postoperative Cushing's syndrome patients with at least one intact adrenal gland. Triggers include postoperative remission (morning cortisol <5 µg/dL or UFC <28–56 nmol/d) and the need to evaluate HPA recovery before glucocorticoid discontinuation.

dromlakhani/MD2SKILL
インストール方法を見る

含まれるファイル（1）

  • SKILL.md3.5 KB

SKILL.md（原文）

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Follow-Up Testing to Assess HPA Axis Recovery in Cushing's Syndrome Patients

STEP 1 — Gather Information

Collect postoperative remission status (morning cortisol <5 µg/dL or UFC <28–56 nmol/d), surgical history confirming ≥1 intact adrenal gland, current glucocorticoid dose/timing, and contraindications to testing (e.g., insulin hypoglycemia: seizure history, CAD). If criteria met, proceed to STEP 2; otherwise, do not use this skill for HPA assessment.

STEP 2 — Rule In / Rule Out

Is the patient in postoperative remission (morning cortisol <5 µg/dL or UFC <28–56 nmol/d) with ≥1 intact adrenal gland and no test contraindications?

  • Yes: Proceed to STEP 3.
  • No: HPA recovery assessment not indicated; manage glucocorticoids based on etiology and clinical judgment.

STEP 3 — Classify or Stratify

Obtain morning cortisol (pre-glucocorticoid dose):

  • ≥18 µg/dL (500 nmol/L): HPA recovered → Proceed to STEP 4 (Decide: discontinue glucocorticoids).
  • <5 µg/dL (138 nmol/L): HPA not recovered → Proceed to STEP 4 (Decide: continue glucocorticoids, retest in 3–6 months).
  • 5–18 µg/dL: Perform ACTH stimulation test or insulin-induced hypoglycemia test.
    • Stimulated cortisol ≥18 µg/dL (500 nmol/L): HPA recovered → Proceed to STEP 4.
    • Stimulated cortisol <18 µg/dL (500 nmol/L): HPA not recovered → Proceed to STEP 4.

STEP 4 — Decide

If HPA axis recovered: Discontinue glucocorticoid replacement, counsel on adrenal insufficiency precautions, and monitor for symptoms.
If HPA axis not recovered: Continue current glucocorticoid dose, schedule repeat testing in 3–6 months, and educate on signs of adrenal insufficiency (e.g., fatigue, hypotension, weight loss).

Clinical Guardrails / Mimics / Pitfalls

  • Do not test morning cortisol after that day’s glucocorticoid dose (invalidates baseline).
  • Insulin hypoglycemia test contraindicated in seizure disorders, coronary artery disease, or uncontrolled hypertension.
  • ACTH stimulation test may falsely low <3 months postop due to adrenal atrophy; delay testing until ≥3 months if early postoperative.
  • Never discontinue glucocorticoids based solely on normal test without assessing for adrenal insufficiency symptoms (mimic: glucocorticoid withdrawal vs. true insufficiency).
  • Pitfall: Misinterpreting borderline results; use clinical correlation (symptoms, ACTH levels) for intermediate values.

Concrete Clinical Example

A 48-year-old woman with Cushing's disease underwent left adrenalectomy for an adenoma. Post-op morning cortisol was 3 µg/dL (remission). On hydrocortisone 15 mg daily. At 5 months post-op, pre-dose morning cortisol was 9 µg/dL. ACTH stimulation test yielded stimulated cortisol 21 µg/dL (≥18). HPA axis recovered → glucocorticoids discontinued. She remains asymptomatic at 6-month follow-up.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Lynnette K. Nieman et al., 2015, DOI: 10.1210/jc.2015-1818

TODO: consider adding scripts/calc.py for the es-cushing-hpa-axis-recovery-assessment calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

ログインしてレビューを書く

同じリポジトリのスキル

概要と使いどころ

780g-pump-adjustment

無料

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-acth-stim-test-interpretation

無料

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-adrenal-crisis-treatment

無料

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-ai-education

無料

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-aed-lt4-monitoring

無料

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

ata-cortisol-cutoff-ai-diagnosis

無料

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する